Letter: loss of response to anti-TNFalpha agents in patients with inflammatory bowel disease depends on treatment duration. Ben-Horin S, Ungar B. Aliment Pharmacol Ther 2022;55:497-498.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ben-Horin S, Ungar B. Letter: loss of response to anti-TNFalpha agents in patients with inflammatory bowel disease depends on treatment duration. Aliment Pharmacol Ther 2022;55:497-498.
PMID: 35092047